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Abstract
The Hfq protein is reported to be an RNA chaperone, which is involved in the stress response and the virulence of several
pathogens. In E. coli, Hfq can mediate the interaction between some sRNAs and their target mRNAs. But it is controversial
whether Hfq plays an important role in S. aureus. In this study, we found that the deletion of hfq gene in S. aureus 8325-4
can increase the surface carotenoid pigments. The hfq mutant was more resistant to oxidative stress but the pathogenicity
of the mutant was reduced. We reveal that the Hfq protein can be detected only in some S. aureus strains. Using microarray
and qRT-PCR, we identified 116 genes in the hfq mutant which had differential expression from the wild type, most of which
are related to the phenotype and virulence of S. aureus. Among the 116 genes, 49 mRNAs can specifically bind Hfq protein,
which indicates that Hfq also acts as an RNA binding protein in S. aureus. Our data suggest that Hfq protein of S. aureus is a
multifunctional regulator involved in stress and virulence.
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Introduction
Hfq protein was originally identified in E. coli as a host factor for
the replication of the Qb phage RNA [1] and is considered to be a
multifunctional regulator of a variety of targets in bacteria [2]. Hfq
regulates post-transcriptional gene expression in E. coli, specifically
mRNA translation, stability or polyadenylation [3,4].
Recently most studies have focused on the RNA chaperone
function of Hfq in mediating the interaction between sRNA(small
RNA) and mRNA [5]. In E. coli, some known sRNAs can interact
with Hfq [6]. In Salmonella, Hfq associates with almost half of the
co-immunoprecipitated sRNAs [7]. It is reported that Hfq can
influence the stability of several sRNAs [8–10]. Besides acting as
an RNA chaperone, E. coli Hfq has ATPase activity and can mildly
affect transcription and translation in vitro [11,12].
The inactivation of Hfq in E. coli can affect pleiotropic
phenotypes, such as decreased growth rates, negative supercoiling
of plasmids in stationary phase, increased carbon source oxidation,
and increased sensitivity to ultraviolet light [13]. Hfq is also
involved in stress response or virulence of a variety of pathogenic
bacteria, such as Neisseria meningitides, Salmonella, Vibrio cholerae and
Pseudomonas aeruginosa [7,14–19].
Staphylococcus aureus, a major Gram-positive pathogen, can cause
a broad range of diseases, from minor skin infections to life-
threatening diseases, such as toxic shock syndrome and septicemia
[20]. Many reports identify that RNAIII can act as antisense RNA
and regulate the expression of several virulence genes, such as spa
(Staphylococcal protein A, an important virulence factor of S.
aureus) and hla (alpha-toxin gene, a major virulence factor of
S. aureus) [21]. There is also an Hfq-like protein (8.9kD) in S. aureus,
which can form homo-hexamer [22]. The structure of Hfq-
binding RNA has been identified [3,22]. Under in vitro condition, it
is found that Hfq can specifically bind RNAIII and spa mRNA,
which suggests that S. aureus Hfq can also act as an RNA
chaperone [23]. However, Bohn et al. showed that Hfq did not
play a crucial role in stress response, spa mRNA expression, or
exoprotein expression in S. aureus RN6390, COL and Newman.
They also tested ,2000 phenotypes in the RN6390 hfq mutant by
the Phenotype Microarray (PM) Technology [24], and found Hfq
was not involved in the stress response, resistance to several
chemical agents, or metabolic pathways [24]. It was also reported
that S. aureus Hfq could not affect SA1000 expression, which is a
fibrinogen-binding protein and identified as a target of RNAIII
[25]. Geisinger et al. suggested that the weak transcription of hfq
was possibly due to the loss of the gene’s major promoter [26].
In this study, we found the carotenoid pigment increased in the
hfq mutant of S. aureus 8325-4 (Dhfq-8325) and the mutant was less
toxic during infection of MDBK cell and a mouse model of
peritonitis than its parental strains. The results of the microarray
studies showed that the expression of the 116 genes was altered in
Dhfq-8325. We also found that 48 mRNAs of the 116 genes can
specifically bind Hfq, which suggests that Hfq may be an RNA
binding protein. We believe Hfq is a multifunctional regulator of
gene expression and plays a major role in the infection of S. aureus.
Our conclusion is contrary to the finding by Bohn et al. The
difference of these findings may be due to differing expression
patterns of the Hfq protein in different S. aureus strains.
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Deletion of Hfq in S. aureus 8325-4 increased the
carotenoid pigments
We constructed the hfq gene deletion mutant (Dhfq-8325)
derived from S. aureus 8325-4. The result showed that Dhfq-8325
displayed high intensities of yellow pigmentation compared to the
wild type strain. After the restoration of Hfq activity in Dhfq-8325,
the color of the restored strain (rs-hfq-8325) was recovered
(Figure 1A, 1B).The intensity of the yellow carotenoid pigment
of S. aureus is one of the classical criteria for identification of this
species. The genes of crtM and crtN, which encode dehydrosqua-
lene synthase and dehydrosqualene desaturase respectively, are
essential for the pigment’s synthesis of S. aureus. Both genes are
located in the same operon [27]. We quantified the mRNA level of
crtM in 8325-4, Dhfq-8325 and rs-hfq-8325 by qRT-PCR, and
showed that the mRNA level of crtM increased in Dhfq-8325
(Figure 1C). This may explain why the carotenoid pigment of
Dhfq-8325 was increased.
It was reported that the pigment acted as an antioxidant for S.
aureus’ resistance to neutrophil killing [28]. We tested the
susceptibility of Dhfq-8325 to oxidant, and showed that Dhfq-8325
wasindeedmore resistanttooxidantthan the wild type (Figure2A,
2B).Inaddition,wefoundthat the numberofthemutantbacterium
survived in neutrophils was significantly larger than that of the wild
type (Figure 2C). We also found that Dhfq-8325 didn’t display
other phenotypic variations including biofilm formation, cell
growth, surface charge and hydrophobicity (data not shown).
The bacterial strains used in the work of Bohn et al. were
RN6390, COL and Newman, which were different from the ones
in our work [24]. Although the mRNA of hfq could be detected in
such strains by RT-PCR, we wondered whether this mRNA could
be translated into the protein. So we extracted the same amount of
total cellular proteins from 8325-4, RN6390 and other 11 strains,
and detected the expression of Hfq by Western blot with the
specific anti-Hfq antibodies prepared in our lab. The results
revealed that Hfq protein could be found in 8325-4 and other 7
strains, but not in COL and RN6390 (Figure 3). The lack of Hfq
may explain the non-detectable effect of Hfq in S. aureus COL and
RN6390 in the work of Bohn et al. [24]. The sequences of all the
genes encoding Hfq protein including their promoter regions in
these strains are confirmed to be the same (data not shown). We
also compared the transcription of hfq in 8325-4 and RN6390 by
qRT-PCR using 16S rRNA as the control. No significant
difference was observed (data not shown). This result suggested
that there might be some post-transcription regulation of Hfq
protein. Recently Becher et al. reported that mRNA of hfq
(SACOL1324) could be detected in COL by DNA microarray, but
the Hfq protein was undetectable [29]. This result is consistent
with our observation. The different expression profiles of Hfq in S.
aureus strains needs further investigation.
Dhfq-8325 was susceptive to the whole blood killing in
spite of its increased golden pigments
The work of Liu et al. showed that the number of DcrtM-8325
survived in the whole blood decreased compared with WT
because of reduced pigment synthesis [28]. We performed a
similar experiment to verify whether Dhfq-8325 was more resistant
to the whole blood than wild type. It was surprising that the
number of surviving Dhfq-8325 cells was significantly less than the
wild type (Figure 4). These results suggest that some other
regulators in Dhfq-8325 might be more important than the
pigments for S. aureus survival in the whole blood.
Figure 1. Effect of hfq deletion on pigmentation. S. aureus strains WT, Dhfq-8325 and rs-hfq-8325 were cultured for 12 h. The pigments of
different strains were determined. The carotenoid pigment of Dhfq-8325 was increased (A) and showed the characteristic triple peak spectral profile
of carotenoid (B). However, the color of rs-hfq-8325 was similar to the wild type. The expression level of crtM was detected by qRT-PCR. The results of
qRT-PCR showed that the expression of crtM was increased in Dhfq-8325 and recovered in rs-hfq-8325 (C). The results shown were representative of
three independent experiments (* P,0.01). WT, S. aureus 8325-4; Dhfq-8325, 8325-4 with an hfq::kan mutation; rs-hfq-8325, the restoration of Hfq
activity in Dhfq-8325.
doi:10.1371/journal.pone.0013069.g001
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It is well known that the secreted toxins are important for
infection caused by S. aureus. We compared the cytotoxicity of the
hfq mutant with that of the wild type. After incubation with the
supernatants from different strains, the survival cell numbers were
quantified by CCK8 assay. We found that the toxicity of the
supernatant of Dhfq-8325 significantly decreased compared to its
parental stain (Figure 5). However, the cytotoxicity of the
supernatant of RN6390 and COL did not alter after the hfq gene
deletion (Figure 5). In order to investigate if Hfq protein could
influence the toxicity in other strains besides 8325-4, we
constructed an hfq-deletion mutant from ATCC25923, which
was an Hfq positive strain (Figure 3). Similarly, the survival
percentage of cells after treatment of the supernatant of
ATCC25923 was lower than that of the hfq mutant (Figure 5).
The apoptosis and necrosis of MDBK cells induced by the
supernatant was tested using flow cytometry. We found that the
percentage of apoptosis and necrosis induced by the supernatant of
Dhfq-8325 was significantly lower than that of the wild type
(Figure 6). In our further study, the pathogenicity of Dhfq-8325
was assessed in a murine peritonitis model, with an equal number
of bacterium from the wild type and Dhfq-8325 injected
Figure 2. Dhfq -8325 shows enhanced resistance to oxidant and neutrophil killing. The oxidant susceptibility assays were performed to
detect the susceptibility of Dhfq-8325 to oxidative stress. S. aureus cells were incubated with oxidants or neutrophil. The survival number of bacteria
was determined. The figures showed that Dhfq-8325 conferred enhanced oxidant and neutrophil resistance compared with the wild type (S. aureus
8325-4). The results shown were representative of three independent experiments (* p,0.01). A: the singlet oxygen assay; B: the double oxygen
assay; C: neutrophil survival assays. The results shown were representative of three independent experiments. WT, S. aureus 8325-4; Dhfq-8325, 8325-
4 with an hfq::kan mutation; rs-hfq-8325, the restoration of Hfq activity in Dhfq-8325.
doi:10.1371/journal.pone.0013069.g002
Figure 3. The detection of Hfq in the different S. aureus strains by Western blot. The total cellular proteins from the S. aureus cells at the
same growth phase were extracted from different S. aureus strains, and the equal quantity of proteins was loaded to SDS-PAGE. The expression of Hfq
was tested with the specific antibodies of Hfq by Western blot. The recombinant Hfq protein was used as a control. Lanes: 1, Molecular Weight
Marker; 2, recombinant Hfq protein; 3, 040196; 4, 040188; 5, ATCC25923; 6, COL; 7, RN6390; 8, MRSA8963; 9, MRSA8972; 10, MRSA9004; 11, MRSA8973;
12, MRSA8979; 13, 8325-4; 14, Dhfq-8325; 15, rs-hfq-8325.
doi:10.1371/journal.pone.0013069.g003
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different time points (6 h, 10 h, 20 h, 24 h and 30 h), the survival
number of the Dhfq-8325 group was larger than that of the wild
type group(Figure 7A), which was consistent with the results of
the whole blood survival assay and the cytotoxicity assay. The
pathogenicity of Dhfq-25923 was also assessed in the same murine
peritonitis model, and the result showed that the survival number
of the Dhfq-25923 group was larger than that of ATCC25923
group (Figure 7B).
Identification of the changed genes in ?hfq-8325 using
microarray assay
The phenotype and pathogenicity of Dhfq-8325 were different
from that of the wild type, so we analyzed the global change of
gene expression in Dhfq-8325 by microarray. The results revealed
that the expression levels of 116 genes were altered in Dhfq-8325
(fold change$1.5), most of which were involved in the stress
response and pathogenicity of S. aureus. Among the 116 genes, 33
had declined expression level (Table S1), while 83 had elevated
expression level, compared to the wild type (Table S2). It was
found that the level of crtM in Dhfq-8325 was increased, which was
consistent with the result of qRT-PCR. The expression of some
virulence genes (such as serine protease, cysteine protease and
staphylococcal nuclease) and global regulators (such as sarA) was
changed after hfq deletion, which could affect the pathogenicity of
Dhfq-8325. In order to validate the microarray data, the level of
four genes (two up-regulated genes and two down-regulated in
Dhfq-8325) was tested. The results of qRT-PCR were consistent
with the microarray data (Figure 8).
Although it remained controversial whether Hfq plays an
important role in S. aureus, it has been confirmed that Hfq protein
could specifically bind RNAIII [23]. We obtained the RNAs that
could potentially bind Hfq protein by immunoprecipitation in vitro
and these RNAs were further analyzed by microarray. We
identified about 300 mRNAs which were enriched in the pool of
Hfq IP, including RNAIII (Table S3). Then we compared these
RNAs with the 116 genes identified in Dhfq-8325 (Table S1, S2),
and we found that 49 of the 116 genes in Dhfq-8325 were enriched
in the pool of RNAs that bind Hfq protein. It is likely these genes
may be regulated by Hfq.
Discussion
Hfq was discovered as an E. coli host factor required for
replication of RNA phage Qb [1]. Hfq protein belongs to the large
family of Sm and Sm like proteins. The sequence alignment shows
that E. coli Hfq protein and S. aureus Hfq have the conserved Sm1
sequence motif, and the resolved structures show both of them can
form homo-hexameric stuctures [3]. More recent studies show that
Hfq protein can act as an RNA chaperone to mediate RNA-RNA
interaction in E. coli [10]. But it is controversial whether Hfq plays
an important role in S. aureus. Many reports reveal that S. aureus
RNAIII acts as an antisense RNA to regulate its target genes
expression [23,25,26], and it is a potential target of S. aureus Hfq in
vivo [23]. However, Boisset et al. found that Hfq protein exerted no
Figure 4. The survival number of different strains in whole
blood. S. aureus cells were incubated with human whole blood. The
survival bacterial number was detected. Compared with its parental
strain,theDhfq-8325strainwas moresensitivetowhole bloodkilling.The
results shown were representative of three independent experiments
(* p,0.01). WT, S. aureus 8325-4; Dhfq-8325, 8325-4 with an hfq::kan
mutation; rs-hfq-8325, the restoration of Hfq activity in Dhfq-8325.
doi:10.1371/journal.pone.0013069.g004
Figure 5. Detection of the percentage of survival cell using CCK8 assay. The supernatants from different strains were collected by
centrifugation and incubated with MDBK cells for 12 h at 37uC. Cell survival was determined by CCK8 assay. The supernatant of Dhfq-8325 was less
cytotoxic than that of wild type (* p,0.01).
doi:10.1371/journal.pone.0013069.g005
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RNAIII stability in S. aureus RN6390 [25]. Furthermore Bohn et al.
reported that the deletion of Hfq had no noticeable effect on
virulence gene expression nor was this protein highly expressed in
S. aureus RN6390 [24].
In our work, we found that the deletion of Hfq can increase the
pigments synthesis in 8325-4, while the color of the bacteria was
recovered after the hfq gene was restored in Dhfq-8325. These
results suggest that Hfq can influence the phenotype of S. aureus.
The reason why our conclusion is different from that of Bohn et al.
may be due to the different strains used in the experiments.
Although S. aureus 8325-4 and RN6390 both originate from S.
aureus 8325, the RN6390 has been generated by three rounds of
transduction from 8325-4, and they have been validated to be
different strains [30–32]. We also found that the Hfq protein can
be detected in 8325-4 and other strains, but not in RN6390. The
lack of Hfq expression may explain that there were no detectable
changes induced by inactivation of Hfq in some strains. The
reason why Hfq can not be detected in some strains is not clear
and is now being investigated in our lab.
Although the pigments increased in Dhfq-8325, we found the
survival number of Dhfq-8325 in the whole blood decreased
significantly and the Dhfq-8325 was less toxic to mammalian cells
and mice. These results suggest that the pigments are just one
factor of S. aureus pathogenicity and there may be some other more
crucial factors regulated by Hfq. We then compared the gene
expression profile of Dhfq-8325 with that of wild type. The
transcription analysis showed that the expression of many genes
was altered. Several serine protease and cysteine proteases (such as
sspA, sspB and splC) were down-regulated in Dhfq-8325 and
identified as the important factors for S. aureus infection. A
transposon mutant of the ssp operon had an attenuated virulence
in three separate animal models (mouse abscess, bacteremia and
wound infection) [33]. This may explain why the pathogenesis of
Dhfq-8325 was decreased in the animal model.
Some recent researches have suggested that the studies defining
the regulatory roles of sarA and agr using RN6390 are not always
representative of the events that occur in clinical isolates of S. aureus
[34,35]. So we constructed an hfq deletion mutant from
ATCC25923, which is a clinical isolate, to investigate the
Figure 6. Flow cytometric analysis of the percentage of apoptosis and necrosis of cells. The apoptosis and necrosis of MDBK cells treated
with the supernatant of S. aureus was detected by flow cytometry. The figure shows the summary data of the percentage of normal, apoptosis and
necrosis of MDBK cells after the challenge of supernanant of different strains. The percentage of apoptosis and necrosis induced by the supernatant
of Dhfq-8325 was lower than wild type. The final data represented the mean 6 SD for three independent experiments (* p,0.01).
doi:10.1371/journal.pone.0013069.g006
Figure 7. The pathogenicity of the hfq deletion mutant was decreased in the animal model. The pathogenicity of the hfq deletion
mutants was assessed in a murine peritonitis model. S. aureus cells were injected intraperitoneally into the mice (10 mice per group). Survival of mice
was recorded at the different time points. The result showed that the survival number of the hfq deletion mutants group was larger than that of the
wild type group at each time point.
doi:10.1371/journal.pone.0013069.g007
Hfq Control Pathogenicity
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and pathogenesis of the Dhfq-25923 was significantly decreased as
compared to its parental strain which suggests that Hfq can
influence the toxicity of lab strains and clinical isolates.
The RNA chaperone activity of S. aureus Hfq has not been
confirmed [23–25]. Although Hfq protein of E. coli has a longer C
terminal-tail than that of S. aureus, the tail appears to be dispensable
in the RNA binding function of Hfq [3]. Here we obtained the
RNAs that bind Hfq in S. aureus 8325-4 by immunoprecipitation.
The binding RNAs were then identified using microarray techno-
logy. We found that about 40% of the mRNAs of the changed genes
in Dhfq-8325 could specifically bind Hfq protein. The results suggest
that the Hfq protein in S. aureus can also act as an RNA binding
protein such as in E. coli. We are investigating the mechanism how
these genes can be regulated by Hfq directly or indirectly.
Materials and Methods
Ethics Statement
All animal experimental protocols of the study are in
accordance with the national guidelines for the use of animals in
scientific research. It’s also approved by Animal Care and Use
Committee of Beijing Institute of Basic Medical Sciences, with the
approval number BMS-081210.
Bacterial strains and growth conditions
The strains used in this study are listed in Table 1. Strains were
grown in 5 ml of brain heart infusion (BHI, BD) or Luria-Bertani
(LB) medium at 37uC for 12 h with shaking at 200 rpm in a 25-ml
test tube. Cells from 1 ml of pre-culture were transferred to 100 ml
of BHI or LB medium in a 500-ml flask and incubated at 37uCo n
a rotary shaker at 200 rpm. S. aureus strains were routinely grown
in BHI and E. coli strains were grown in LB medium either with no
antibiotics, or with 20 mg/ml erythromycin, 100 mg/ml ampicillin
and 50 mg/ml kanamycin.
Expression and purification of Hfq protein
The hfq gene was amplified from the genome of S. aureus 8325-4
with the primers (hfq NcoI and hfq XhoI) in Table 2. The PCR
product was cloned into the expression vector pET28(a) as an
NcoI-XhoI fragment, generating pET28(a)-hfq, which was subse-
quently transformed into E. coli strain BL21 (DE3). Expression of
the recombinant Hfq protein was induced by adding 0.1 mM
isopropyl b-D-thiogalactopyranoside (IPTG) to a growing culture
at OD600=0.4. Purification of recombinant protein on Q
Sepharose Fast Flow and SP Sepharose Fast Flow columns
(Amersham Biosciences) was carried out according to the manu-
facturer’s instructions.
Production of polyclonal antibodies against Hfq
Female New Zealand White rabbits were first immunized by
subcutaneous injection with 1 mg of Hfq protein in Phosphate
Buffered Saline (PBS) mixed with complete Freund’s adjuvant in a
total volume of 1 ml. And the subsequent booster injections, i.e.,
1 mg of Hfq in PBS emulsified in incomplete Freund’s adjuvant,
were administered at 3 and 6 weeks after the primary immuni-
zation. At the eighth week, the sera were collected and the
antibody titers were determined by ELISA.
Figure 8. qRT-PCR quantification of the expression of sspB, nuc, sarA and capJ. The expression level of sspB, nuc, sarA and capJ was detected
by qPCR. The results of qRT-PCR were accordant to the microarray data. The results shown were representative of three independent experiments
(* P,0.01).
doi:10.1371/journal.pone.0013069.g008
Hfq Control Pathogenicity
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The mutant was constructed using the method described
previously [36] with some modifications. In order to create a
deletion mutant of hfq in the chromosome of 8325-4, two regions of
DNAflankingthehfqgenewereamplifiedbyPCRusingtheprimers
(Up-hfq F-EcoRI and Up-hfq R-KpnI; Down-hfq F-KpnI and
Down-hfq R-SalI) with restriction sites listed in Table 2. The
upstream fragment (659 bp) was digested with EcoRI and KpnI, and
the downstream fragment (680 bp) was digested with KpnI and SalI.
The two fragments were cloned together into pMD19T digested
with EcoRI and SalI. The resulting construct was digested with KpnI,
and then a 1.6-kb kanamycin cassette which was amplified from the
plasmid of pTZ-TRAP::kan provided by Dr. Balaban N was
inserted. The resulting plasmid was digested with EcoRI and SalI,
and a fragment harboring kanamycin resistance between the
upstream and downstream fragments was ligated into pAUL-A
digested with EcoRI and SalI to create plasmid pAUL-A-Dhfq.
pAUL-A has a temperature-sensitive origin of replication that is
active in S. aureus at 30uC but not at 42uC. The recombinant
plasmid initially isolated from E. coli, was introduced into S. aureus
RN4220 byelectroporationand coloniesresistanttokanamycinand
erythromycin were selected after growth at 30uC. The resistant
clones were subjected to a temperature shift to 42uC to select the
plasmid integration into the chromosome. Bacteria resistant to
kanamycin but sensitive to erythromycin were selected. The
mutation was confirmed by PCR, and followed by transduction
into strains 8325-4, RN6390, COL and ATCC25923 with
phageW11 to create the mutant strains from which the coding
region of hfq (234 bp) was deleted (Table 1).
Restoring Hfq Activity
Primers rs-hfqF and rs-hfqR (listed in Table 2) were designed to
PCR-amplify a 1406 bp fragment encompassing the gene
encoding for Hfq, the promoter region and termination site with
SalI/EcoRI sites. S. aureus 8325-4 chromosomal DNA was used as a
template. The PCR product (‘‘whole hfq’’) was digested and cloned
into the SalI/EcoRI digested pMAD, which could replicate in E.
coli at 37uC and in S. aureus at 30uC and could be used as a suicide
vector when grown at 42uCi nS. aureus. The resulting plasmid
(pMAD-rs-hfq) was used to transform into E. coli DH5a. Cells
were selected on LB plates containing 100 mg/ml ampicillin.
Plasmid was isolated from positive clones and used to transform S.
Table 1. Bacterial strains and plasmids.
Strain or plasmid Comments Source or reference
Strain
S. aureus
8325-4 Wild-type, rsbU
- [30]
Dhfq-8325 8325-4 with an hfq::kan mutation This study
rs-hfq-8325 Dhfq-8325 restoring Hfq activity This study
ATCC25923 clinical isolate [42]
Dhfq-25923 ATCC25923 with an hfq::kan mutation This study
COL Highly methicillin resistant clinical isolate Dr. William M. Shafer
Dhfq- COL COL with an hfq::kan mutation This study
RN6390 Laboratory virulent strain derived from 8325 [31]
Dhfq-RN6390 RN6390 with an hfq::kan mutation This study
RN4220 Restriction-negative strain, 8325 derivative [43]
MRSA 8963 Methicillin resistant clinical isolate professor Jingui Cao
MRSA 8972 Methicillin resistant clinical isolate professor Jingui Cao
MRSA 8973 Methicillin resistant clinical isolate professor Jingui Cao
MRSA 8979 Methicillin resistant clinical isolate professor Jingui Cao
MRSA 9004 Methicillin resistant clinical isolate professor Jingui Cao
040188 Laboratory strain stored in our lab
040196 Laboratory strain stored in our lab
E. coli
DH5a A host strain for cloning Transgene
BL21(DE3) A host strain for protein expression Transgene
Plasmids
pMD19T E.coli cloning vector, amp
R TaKaRa
pMD20T E.coli cloning vector, amp
R TaKaRa
pET28 (a) E.coli expression vector, kan
R Novagen
pAUL-A Temperature-sensitive S. aureus suicide vector; Em
R [44]
pAUL-A-Dhfq pAUL-A containing whole hfq gene This study
pMAD Temperature-sensitive S. aureus suicide vector; Em
R [45]
pMAD-rs-hfq pMAD containing whole hfq gene for restoring Hfq activity This study
doi:10.1371/journal.pone.0013069.t001
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agar plates containing 10 mg/ml erythromycin at 30uC. Then the
plasmid was isolated from the positive clone (RN4220 containing
pMAD-rs-hfq) and transformed to Dhfq-8325 by electroporation.
The transformants were selected on tryptic soy agar plates
containing 10 mg/ml erythromycin at 30uC for 48 h, and then
transferred to 42uC for 12 h. The restoring colonies (rs-hfq-8325)
were confirmed by PCR and RT-PCR analysis.
Oxidant susceptibility assay
The assay to test susceptibility to oxidants was performed as
previously described [37] with some modifications. For hydrogen
peroxide susceptibility assay, S. aureus cells were grown to early
exponential phase and harvested by centrifugation. Hydrogen
peroxide (H2O2) was added at a 1.5% final concentration to the
bacteria (2610
9/ml) and incubated at 37uC for 1 h. Then,
1,000 U/ml of catalase (Sigma-Aldrich) was added to quench
residual H2O2. Dilutions were plated on tryptic soy agar plates for
enumeration of surviving cells.
The assay to test susceptibility to singlet oxygen was performed
as previously described [37] with some modifications as well. S.
aureus strains were grown to early exponential phase and harvested
by centrifugation. The bacteria (10
8/ml) were incubated at 37uC
in a 24-well culture plate. 200 ml of 0.1 mg/ml methylene blue was
added to the wells and the plate was situated at exactly 10 cm from
a 100-W light source. The viable cells were assessed after 1.5 h by
plating dilutions on tryptic soy agar plates.
Neutrophil intracellular survival assay
Neutrophils for intracellular survival assays were purified from
healthy human volunteers as previously described [37]. Bacteria
were washed twice in PBS, diluted to a concentration of
4.5610
6 CFU (colony forming unit) in 100 ml RPMI1640 with
10% fetal calf serum and mixed with 3610
5 neutrophils in the
same media. The mixture was centrifuged at 700 g for 5 min, and
then incubated at 37uC in a 5% CO2 incubator. After 10 min
gentamicin was added to a final concentration of 400 mg/ml for
killing the extracellular bacteria. Then, the contents of sample
wells were withdrawn and centrifuged to pellet the neutrophils.
Neutrophils were washed twice, and then lysed in 0.02% Triton
X-100. CFU was calculated by serial dilution plated on Todd-
Hewitt agar (THA; 1.5% agar in Todd-Hewitt broth) plate.
Whole-blood killing assay (WBKA)
S. aureus strains were grown for 12 h and harvested by
centrifugation (10,000 g, 1 min). Bacteria were washed twice in
PBS, and then 1610
4 cells were diluted to the volume of 25 mli n
PBS, and mixed with 75 ml freshly drawn mouse blood in
heparinized tubes. The tubes were incubated at 37uC for 4 h with
agitation, and then surviving cells were enumerated by plating the
dilutions on THA plates.
Cytotoxicity assay
The supernatant of S. aureus was collected as described [38,39]
with some modifications. Briefly, S. aureus cells were grown to
stationary phase at 37uC. Growth culture was centrifuged at
6,000 g for 10 min at 4uC. The supernatant was collected and
filtered through a 0.22 mm filter to remove residual cells.
Madin-Darby Bovine Kidney (MDBK, ATCC-CCL22) cells
were resuspended at a concentration of 1610
5 cells/ml and added
to a 96-well plate (100 ml/well) at 37uC in a 5% CO2 incubator for
6 h. The supernatant of S. aureus strains (5 ml/well) was added, with
BHI broth as the control. The CCK8 assay was used to test the
number of survival cells as per the protocol (Dojindo) after 12 h
incubation. The cell viability percentage was calculated as: Viability
percentage (%) = (Absorption value of supernatant of treatment
group)/(Absorption value of supernatant of control group)6100%.
For flow cytometric analysis, the MDBK cells were resuspended
at a concentration of 1610
6 cells/ml and added to a 12-well plate
(1 ml/well) at 37uC in a 5% CO2 incubator for 6 h. The cultivated
cells were incubated with BHI or with supernatant (100 ml/well) of
S. aureus strains for 1 h. Prior to harvesting, the cells were washed
twice with PBS, trypsinized, and pelleted. Then cells were
resuspended at a concentration of 1610
6 cells/ml in Binding
Buffer (0.01 M HEPES/NaOH, pH 7.4, 14 mM NaCl, 0.25 mM
CaCl2). 500 ml aliquots of cells were added into FACS tubes and
mixed with 25 ng/ml fluorescein isothiocyanate–labeled annexin
V and 10 mg/ml propidium iodide (PI) to incubation for 15 min
at room temperature in the dark. Then the cells were analyzed
immediately by flow cytometry.
RNAs binding to Hfq were obtained by
immunoprecipitation
The immunoprecipitation assays were prepared as described
previously [23] with some modifications. The purified Hfq protein
(100 mg) was incubated with 5 ml rabbit immune serum
containing S. aureus Hfq-specific antibodies or rabbit normal
serum at 37uC for 30 min. The captured antibodies were then
bound to 1 ml of protein A sepharose CL-4B (Sigma-Aldrich) at
37uC for 30 min. After four washes with 2 ml washing buffer
(50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.5% Triton X-100),
the total RNA of S. aureus was added and incubated at 37uC for
30 min. After another four washes with 2 ml washing buffer, the
binding complexes were eluted from protein A sepharose with
1 ml of 0.1 M Glycine–HCl, pH 2.5, and neutralized with 100 ul
Table 2. Sequences of forward and reverse primers used in
this study.
Primer/sequence Oligonucleotide sequence (59 to 39)
hfq NcoI CATGCCATGG GCATGATTGCAAACGAAAACAT
hfq XhoI CCGCTCGAGTTATTCTTCACTTTCAGTAGATG
16S F GCCTAATACATGCAAGT
16S R CATGTTATCCGGCATTAG
Up-hfq F-EcoRI CATCCGGAATTCCCAATCATAGCAGGTGGAAC
Up- hfq R-KpnI TCACTTGGTACCCTGTCGGACTCCTTTTACT
Down- hfq F-KpnI CGACAGGGTACCAAGTGAAGAATAAGTTGTAA
Down- hfq R-SalI ACACGCGTCGACCAAATAAAGG TGTTACTTAC
rs-hfqF TCTAGATAGTCGACTATTCACCCTAACAA
rs-hfqR GATATGCATGAATTCATGGAGACAATTTAT
crtM RT primerF GACTTGGTGAATCGTTGC
crtM RT primerR CTATGATTGGTGATGCTTC
sspB RT primerF AAACGAAGCGATACAAGA
sspB RT primerR CATTTGATTAGGGAATGTTG
nuc RT primerF GTAGCCATCATTATTGTAG
nuc RT primerR CCATAGCGATCTTGTTTT
sarA RT primerF CTCAAGAAGATTACTTCGAT
sarA RT primerR GCTTCAGTGATTCGTTTA
capJ RT primerF ATATCTACAAGGTGGAAC
capJ RT primerR CCCTAATAAGCCAAATGA
doi:10.1371/journal.pone.0013069.t002
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phenol, followed by RNA precipitation and the RNAs which were
bound to Hfq were analyzed by microarray. Calculation of
enrichment factor was performed as follows: enrichment factor =
signal intensities of Hfq IP/signal intensities of control IP.
Transcriptional microarray analysis
Gene expression profiles of the Dhfq-8325 and wild type strains
were analyzed by using Affymetrix S. aureus arrays as described
previously [40] with some modifications as follows. The S. aureus
array contains probe sets to over 3,300 S. aureus open reading frames
(ORFs)and 4,800 intergenicregion sequencesbased on the updated
S. aureus genomic sequences of N315, Mu50 and COL [41]. Total
bacterial RNA was extracted from S. aureus which were grown for
6 h with shaking at 37uC using Trizol (Invitrogen) as previously
described [41]. DNase digestion of 80 ml of total RNA was
performed with 10 U of RNase-free DNase I (Promega) and 10 ml
of the 106reaction buffers in a total reaction volume of 100 ml for
30 min at 37uC. The RNA (10 mg) was reversely transcribed to
cDNA by using M-MLV reverse transcriptase (Promega) and
random primers (Promega) for 1 h at 42uC. The fragmented
cDNAs were then directly labeled with biotin by using a biotin-
ddUTP kit (Affymetrix). Biotinylated cDNA was hybridized to the
GeneChips. Microarrays were scanned using an Affymetrix
GeneChip Scanner 3000 and image data were extracted using
GeneChip Operating Software (GCOS) Version 1.4. Two inde-
pendent labeling reactions and hybridizations were carried out for
each RNA sample. This experiment was completed by Bioassay
Laboratory of CapitalBio Corporation. Normalization and expres-
sion analysis were performed with DNA-chip analyzer (dChip).
Invariant set normalization was used to normalize arrays at the
probe level. Genes with variations (n-fold$1.5) were collected. All
data is MIAME compliant, and the raw data has been deposited in
the database ArrayExpress (No. E-TABM-1005).
Acute murine peritoneal infection model
Groups (n=10) of 6- to 8-week-old, male Balb/c mice were
injected intra-abdominally with 500 ml of different strains. The
injected cell number of Dhfq-8325 or S. aureus 8325-4 was
1610
8 CFU per mouse. And the injected cell number of Dhfq-
25923 or ATCC25923 was 5610
8 CFU per mouse. The survival
number of mice was recorded at the different time points (6 h,
10 h, 20 h, 24 h and 30 h) post challenge. Survival outcomes in
the wild type or the Dhfq-8325 groups were compared.
Preparation of S. aureus total proteins and Western blot
The cell extract was prepared as described [41] with some
modifications as follows. Cells were grown for 6 h with shaking at
37uC. Equal numbers of cells (1610
10 CFU) were collected and
then resuspended in 1 ml PBS buffer containing lysostaphin
(100 mg/ml, Sigma-Aldrich). After incubation for 30 min at 37uC,
the mixture was centrifuged at 13,000 g for 10 min and the
precipitate was resuspended in 1 ml PBS. The mixture was
sonicated on ice three times for 30 s each and centrifuged at
13,000 g for 10 min. The supernatant was precipitated by adjusting
filtered supernatants to 10% trichloroacetic acid (TCA) and
incubated at 4uC for 4 h. After centrifugations at 12,000 g for
10 min, precipitated proteins were washed twice in ice-cold 96%
ethanol, and air dried. The proteins were resolved in an appropriate
volume of a solution containing 7 M urea and 2 M thiourea. The
samples were then subjected to 15% SDS-PAGE and the proteins
were blotted onto Hybond-ECL nitrocellulose membrane (Amer-
sham Biosciences). The membrane was blocked in 5% non-fat dry
milk at 37uC for 2 h, probed with 1:500 diluted polyclonal rabbit
anti-Hfq antibodies (prepared by ourselves) for 1 h at room
temperature, and washed twice in PBS with 0.5% Tween 20
(PBST). Then the membrane was incubated in a 1:5,000 solution of
HRP-conjugated goat anti-rabbit secondary antibody (Jackson) at
room temperature for 1 h. After further washing with PBST, the
membrane was assayed by the enhanced chemiluminescence (ECL)
Western blotting detection system (Pierce).
Quantitative reverse transcription PCR (qRT-PCR)
For cDNA synthesis, 1 mg of total RNA was mixed with 500 ng
of random hexamer (Promega). Samples were incubated at 65uC
for 10 min with 5 mlo f5 6 first-strand buffer, 2 mlo f5m M
dNTP, 2 0U of RNasin (Takara), 1 ml of M-MLV reverse
transcriptase (Promega) and distilled water to a total volume of
25 ml. The qPCR reaction mixture contained 12.5 mlo f2 6SYBR
green PCR mix (GenePharma), 0.3 mM of gene-specific forward
and reverse primers, and 1 ml of template, made up to a final
volume of 25 ml with distilled water. The primers are shown in
Table 2. Cycling parameters were set as follows: initial activation
step at 95uC for 10 min, denaturation at 94uC for 30 s, annealing
at 58uC for 30 s, and extension at 72uC for 40 s. Melting curve
analysis was performed at from 58uCt o9 5 uC with stepwise
fluorescence acquisition at every 1uCs
21. Melting curves observed
for each gene were confirmed to correspond to the correct
amplicon size by agarose gel electrophoresis of the PCR products.
The levels of gene expression were calculated by relative
quantification using 16S rRNA as the endogenous reference gene.
All samples were amplified in triplicate and the data analysis was
carried out using the MxPro qPCR system software (Stratagene).
Statistical analysis
All quantitative data were analyzed using Student t-tests.
P,0.05 was considered to be statistically significant.
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